Back to results
RecruitingPhase 2

Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer

NCT03971045

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Istituto Europeo di Oncologia

Milan, Italy

Contact

Giuseppe Curigliano, MD PhD

+390257489001giuseppe.curigliano@ieo.it
View on ClinicalTrials.gov
Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer — TrialFind